MENA

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

LONDON, July 02, 2024 (GLOBE NEWSWIRE) — Leading international residence and citizenship advisory firm Henley & Partners, in partnership with Andan Foundation, a Swiss non-profit humanitarian organization, is pleased to announce the call for nominations for the 2024 Global Citizen Award. Created ten years ago in 2014, the Global Citizen Award is a tribute that honors remarkable individuals […]

Adrian Ridge TEMECULA, Calif., July 01, 2024 (GLOBE NEWSWIRE) — Effective July 1, 2024, Adrian Ridge is Chief Executive Officer of Nikkiso Clean Energy & Industrial Gases Group, part of Nikkiso Co. Ltd.’s Industrial division. Ridge succeeds Peter Wagner, who remains engaged in a Board role as Executive Chairman for Nikkiso CE&IG Group. As CEO, […]

Adrian Ridge TEMECULA, Calif., July 01, 2024 (GLOBE NEWSWIRE) — Effective July 1, 2024, Adrian Ridge is Chief Executive Officer of Nikkiso Clean Energy & Industrial Gases Group, part of Nikkiso Co. Ltd.’s Industrial division. Ridge succeeds Peter Wagner, who remains engaged in a Board role as Executive Chairman for Nikkiso CE&IG Group. As CEO, […]